IE890087L - Recombinant human interleukin-1 alpha polypeptides - Google Patents

Recombinant human interleukin-1 alpha polypeptides

Info

Publication number
IE890087L
IE890087L IE890087A IE8789A IE890087L IE 890087 L IE890087 L IE 890087L IE 890087 A IE890087 A IE 890087A IE 8789 A IE8789 A IE 8789A IE 890087 L IE890087 L IE 890087L
Authority
IE
Ireland
Prior art keywords
polypeptides
human interleukin
recombinant human
contain
alpha polypeptides
Prior art date
Application number
IE890087A
Original Assignee
Kobe Steel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobe Steel Ltd filed Critical Kobe Steel Ltd
Publication of IE890087L publication Critical patent/IE890087L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to homogeneous recombinant human interleukin- 1 alpha polypeptides, to DNA sequences which code for such polypeptides, to recombinant vectors which contain a DNA of this type, to host organisms which contain a recombinant vector of this type, and to methods for the preparation of the said polypeptides. The homogeneous recombinant human interleukin-1 alpha polypeptides and pharmaceutical compositions which contain such polypeptides can be used to stimulate the immune system of a patient, to promote wound healing or to promote the recovery of seriously ill, protein-undernourished patients. [EP0324447A2]
IE890087A 1988-01-15 1989-01-13 Recombinant human interleukin-1 alpha polypeptides IE890087L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14445788A 1988-01-15 1988-01-15

Publications (1)

Publication Number Publication Date
IE890087L true IE890087L (en) 1989-07-15

Family

ID=22508674

Family Applications (1)

Application Number Title Priority Date Filing Date
IE890087A IE890087L (en) 1988-01-15 1989-01-13 Recombinant human interleukin-1 alpha polypeptides

Country Status (19)

Country Link
EP (1) EP0324447B1 (en)
JP (1) JP2567079B2 (en)
AR (1) AR245958A1 (en)
AT (1) ATE142696T1 (en)
AU (1) AU616461B2 (en)
DE (1) DE58909723D1 (en)
DK (1) DK16489A (en)
ES (1) ES2091752T3 (en)
FI (1) FI890175L (en)
GR (1) GR3021887T3 (en)
HU (1) HU208996B (en)
IE (1) IE890087L (en)
IL (1) IL88934A (en)
MC (1) MC2002A1 (en)
NO (1) NO890174L (en)
NZ (1) NZ227594A (en)
PT (1) PT89438B (en)
YU (1) YU6889A (en)
ZA (1) ZA89202B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587605T2 (en) * 1984-12-25 1994-03-17 Dainippon Pharmaceutical Co Interleukin-1 and its derivative.
DE3818660A1 (en) * 1987-06-05 1988-12-15 Colgate Palmolive Co FREE-FLOWING, POWDERY DISHWASHING DETERGENT AND METHOD FOR PRODUCING THE SAME
US5120534A (en) * 1988-07-29 1992-06-09 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and medicament for treating thrombocytopenia
US6191269B1 (en) * 1997-05-30 2001-02-20 The Regents Of The University Of California Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
US7176179B1 (en) 1997-05-30 2007-02-13 The Regents Of The University Of California Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
US20030154504A1 (en) 1998-06-24 2003-08-14 Farese Robert V. Methods and compositions for modulating carbohydrate metabolism
DE10252634A1 (en) * 2002-11-11 2004-05-27 Umwelttechnik Georg Fritzmeier Gmbh & Co. Purification of sewage or other substances laden with harmful organic matter and detergent or clarifying agent also useful laundry and cleaning surfaces involve introduction of photosensitizer releasing singlet oxygen when stimulated
WO2011038754A1 (en) * 2009-09-29 2011-04-07 United Technologies Ut Ag Oral care compositions containing human recombinant interleukin-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587605T2 (en) * 1984-12-25 1994-03-17 Dainippon Pharmaceutical Co Interleukin-1 and its derivative.
DE3683186D1 (en) * 1985-04-25 1992-02-13 Hoffmann La Roche RECOMBINANT HUMANINTERLEUKIN-1.
DE3515217A1 (en) * 1985-04-26 1986-10-30 Siemens AG, 1000 Berlin und 8000 München DEVICE FOR MEASURING LOW MAGNETIC FIELDS
US5017692A (en) * 1986-09-04 1991-05-21 Schering Corporation Truncated human interleukin-a alpha

Also Published As

Publication number Publication date
DK16489A (en) 1989-07-16
FI890175A7 (en) 1989-07-16
JPH025892A (en) 1990-01-10
IL88934A0 (en) 1989-08-15
FI890175L (en) 1989-07-16
EP0324447B1 (en) 1996-09-11
YU6889A (en) 1990-08-31
FI890175A0 (en) 1989-01-13
NO890174D0 (en) 1989-01-13
DE58909723D1 (en) 1996-10-17
HU208996B (en) 1994-09-28
JP2567079B2 (en) 1996-12-25
PT89438B (en) 1993-09-30
AR245958A1 (en) 1994-03-30
GR3021887T3 (en) 1997-03-31
EP0324447A2 (en) 1989-07-19
EP0324447A3 (en) 1990-01-31
IL88934A (en) 1994-05-30
ATE142696T1 (en) 1996-09-15
AU2850989A (en) 1989-07-20
HUT50505A (en) 1990-02-28
ES2091752T3 (en) 1996-11-16
DK16489D0 (en) 1989-01-13
PT89438A (en) 1990-02-08
AU616461B2 (en) 1991-10-31
NO890174L (en) 1989-07-17
ZA89202B (en) 1989-09-27
MC2002A1 (en) 1990-01-26
NZ227594A (en) 1991-09-25

Similar Documents

Publication Publication Date Title
AU1026692A (en) Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
HUP9902429A2 (en) Modulators of tnf receptor associated factor (traf), their preparation and use
EP0853121A3 (en) Human DNase
WO1996034953A3 (en) Cd16-ii variants
IL99401A0 (en) Nucleotide sequence coding for an outer membrane protein and use of said protein in vaccine preparations
ZA943465B (en) Transforming growth factor alpha H1
GB9224584D0 (en) Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
AU6787894A (en) Adenoviral vectors of animal origin and use in gene therapy
NO873699D0 (en) POLYPEPTIDE SUITABLE FOR DIMENSION, TREATMENT AND DIAGNOSIS OF AUTOIMMUNE DISEASES SUCH AS ARTICLES.
IE871967L (en) Binding-factor-related polypeptides
IL81221A0 (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors,biotechnological methods for preparing said proteins and pharmaceutical compositions containing them
IL87391A0 (en) Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
AU7440087A (en) Process for isolating and purifying p. falciparum cs protein vaccine expressed in recombinant e. coli
IL90391A0 (en) Peptides suppressing the function of the immune system,their preparation and pharmaceutical compositions containing them
ZA904565B (en) Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection
IL86852A0 (en) Homologues of human aprotinin,host strains and expression vectors for their preparation and pharmaceutical compositions containing them
NO890174L (en) RECOMBINANT INTERLEUKIN-1ALFA POLYPEPTIDES.
KR880700820A (en) Vascular Factor (PAF)
WO1998035045A3 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
WO1998022580A3 (en) Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
IL83594A0 (en) Human low affinity fce-receptor,its isolation,its recombinant preparation and pharmaceutical compositions containing it
EP0315081A3 (en) Anti-coagulating protein pp4-x, its preparation and use
DK94087D0 (en) PURIFIED HUMAN ANGIOGEN FACTOR, PROCEDURES FOR ITS PREPARATION, AND PHARMACEUTICAL PREPARATIONS
EP1422238A3 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
EP0353516A3 (en) A method for the preparation of recombinant human beta interleukin-1 in the homogeneous form